Intelligent Bio Solutions Inc. (INBS)
NASDAQ: INBS · Real-Time Price · USD
1.410
-0.470 (-25.00%)
At close: Sep 17, 2025, 4:00 PM EDT
1.400
-0.010 (-0.71%)
Pre-market: Sep 18, 2025, 9:00 AM EDT
Intelligent Bio Solutions Market Cap
Intelligent Bio Solutions has a market cap or net worth of $12.73 million as of September 18, 2025. Its market cap has increased by 189.66% in one year.
Market Cap
12.73M
Enterprise Value
11.87M
1-Year Change
189.66%
Ranking
Category
Stock Price
$1.41
Market Cap Chart
Since December 23, 2020, Intelligent Bio Solutions's market cap has decreased from $108.06M to $12.73M, a decrease of -88.22%. That is a compound annual growth rate of -36.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2025 | 12.73M | 107.29% |
| Dec 31, 2024 | 6.14M | 108.12% |
| Dec 29, 2023 | 2.95M | -19.57% |
| Dec 30, 2022 | 3.67M | -82.82% |
| Dec 31, 2021 | 21.36M | -74.44% |
| Dec 31, 2020 | 83.56M | -22.68% |
| Dec 23, 2020 | 108.06M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 682.40B |
| Johnson & Johnson | 426.76B |
| AbbVie | 390.07B |
| UnitedHealth Group | 309.39B |
| Novo Nordisk | 260.64B |
| AstraZeneca | 241.43B |
| Novartis AG | 237.64B |
| Abbott Laboratories | 233.52B |